On September 24, 2024, China-Europe Duisburg Innovation Center Event Series-Innovative Ophthalmic Technology Cooperation Conference was co-hosted by CEST, China-Europe (Duisburg) Innovation Center and Guangzhou Vesber Biotechnology Co., Ltd., in Duisburg. Counselor at the Chinese Consulate-General in Dusseldorf Mr. Xia Yang, Project Manager of Business Development in Greater China of NRW. Global Business Ms. Susanne Baumann, Representative for Chinese Affairs of the City of Duisburg Mr. Markus Teuber, HUB-Manager of Internationalization of Duisburg Business & Innovation Mr. Dominik Bartz, President of Tianjin Medical University Professor Yan Hua, and other guests from both China and Europe attended the event.
As the representative of the hosts, Mr. Zheng Yongqiang, the President of the Chinese Side of the Board of CEST and Chairman of the China-Europe (Duisburg) Innovation Center, extended his warmest welcome and sincere gratitude to all the guests attending this event. Mr. Zheng emphasized that the China-Europe (Duisburg) Innovation Center will continuously focus on life and health, new energy, intelligent manufacturing, intelligent IoT, international logistics and other industry sectors to promote the development of bilateral industries and achieve mutual benefit and win-win results through two-way innovation cooperation between China and Europe. While providing services for enterprises expanding to Europe, they can also invest in companies with strong market potential through venture capital funds and their own capital, helping them grow quickly.
Professor Gao Qianying, Founder and General Manager of Guangzhou Vesber Biotechnology Co., Ltd., introduced Vesber and their products. Guangzhou Vesber Biotechnology Co., Ltd. is a national high-tech enterprise focusing on the research and development, production and sales of innovative ophthalmic products. The company's main products include the Foldable Capsular Vitreous Body (FCVB) and the Foldable Capsular Buckle (FCB).
At the conference, renowned ophthalmology experts and scholars from China, Poland, and Georgia, along with entrepreneurs from both China and Germany, engaged in discussions and exchanges on topics including the development of innovative ophthalmic products and the application of personalized diagnostic technologies. Through the experts' presentations, the attendees gained valuable insights into the latest advancements in global ophthalmic innovation, resulting in a fruitful academic exchange.
An unveiling ceremony was held at the event, which marked the successful entry of the R&D centers of Guangzhou Vesber Biotechnology Co., Ltd., SUNLUX IoT Technology (Guangdong) Inc., and Guangdong Hydrogen Innovation New Energy Co., Ltd. into the China-Europe (Duisburg) Innovation Center. Witnessed by all the guests, representatives of Guangzhou Vesber Biotechnology Co., Ltd. and China-Europe (Duisburg) Innovation Center signed an agreement, which showed Vesber’s commitment to long-term development and its strategic expansion into German and European markets.
